Pluvicto
Payments companies reported to CMS as associated with Pluvicto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pluvicto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pluvicto
These are the largest totals companies reported as associated with Pluvicto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Luke Nordquist | Omaha, NE | Hematology & Oncology | $163,928.02 |
| Neal Shore | Myrtle Beach, SC | Urology | $52,825.75 |
| Alton Sartor | Rochester, MN | Medical Oncology | $29,640.33 |
| Jason Hafron | West Bloomfield, MI | Urology | $28,489.73 |
| Bryan Mehlhaff | Springfield, OR | Urology | $24,706.48 |
| Gordon Brown | Cherry Hill, NJ | Urology | $22,721.07 |
| Shawn Zimberg | Plainview, NY | Radiation Oncology | $19,542.48 |
| Daniel George | Durham, NC | Urology | $17,971.30 |
| Steven Finkelstein | Syracuse, NY | Radiation Oncology | $17,645.36 |
| Ulka Vaishampayan | Ann Arbor, MI | Internal Medicine | $17,519.44 |
Prescribed Pluvicto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.